Illumina, Inc. (ILMN)
$278.17+5.14%Close
BUYBULL · day 37
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $42.1B
- Beta
- 1.42
- P/E (TTM)
- 50.56
- Short % float
- 6.41%
- Days to cover
- 1.6
- SI change
- -10.5%
- 1W
- +1.88%
- 1M
- +38.21%
- vs SPY 1W
- +0.72%
- vs SPY 1M
- +35.22%
Industry peers
FMP comparable companies · ranked by market cap
- NTRABUYNatera, Inc.$57.4BBULLQ 30$400.71+2.54%
- GHSELLGuardant Health, Inc.$22.5BBULLQ 23$167.47+1.15%
- TXGBUY10x Genomics, Inc.$10.2BCRISISQ 12$80.65+4.36%
- BLLNSELLBillionToOne, Inc.$4.5BCRISISQ -7$98.09+2.81%
- WGSSELLGeneDx Holdings Corp.$2.0BCRISISQ -3$67.33-0.59%
- PSNLSELLPersonalis, Inc.$1.7BRECOVERYQ 6$16.00-0.37%
- PACBBUYPacific Biosciences of California, Inc.$724MCRISISQ 4$2.33+1.30%
- SOPHSELLSOPHiA GENETICS S.A.$622MCRISISQ 1$7.41+1.51%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ILMN?
- LOPJLB’s latest quantitative signal on Illumina, Inc. (ILMN) is BUY in a BULL regime. Signals are updated daily.
- What market regime is ILMN in?
- Illumina, Inc. (ILMN) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Illumina, Inc. (ILMN) do?
- Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, an…